NASDAQ:BKYI BIO-key International (BKYI) Stock Price, News & Analysis $0.79 -0.03 (-3.66%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.80 +0.01 (+1.27%) As of 05/23/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About BIO-key International Stock (NASDAQ:BKYI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BIO-key International alerts:Sign Up Key Stats Today's Range$0.76▼$0.8350-Day Range$0.64▼$1.1252-Week Range$0.52▼$3.68Volume58,365 shsAverage Volume2.26 million shsMarket Capitalization$4.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.Read More… BIO-key International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreBKYI MarketRank™: BIO-key International scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for BIO-key International. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of BIO-key International is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BIO-key International is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBIO-key International has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about BIO-key International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.86% of the float of BIO-key International has been sold short.Short Interest Ratio / Days to CoverBIO-key International has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BIO-key International has recently increased by 93.74%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBIO-key International does not currently pay a dividend.Dividend GrowthBIO-key International does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.86% of the float of BIO-key International has been sold short.Short Interest Ratio / Days to CoverBIO-key International has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BIO-key International has recently increased by 93.74%, indicating that investor sentiment is decreasing significantly. News and Social Media1.8 / 5News Sentiment0.19 News SentimentBIO-key International has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for BIO-key International this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for BKYI on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BIO-key International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.80% of the stock of BIO-key International is held by insiders.Percentage Held by InstitutionsOnly 26.51% of the stock of BIO-key International is held by institutions.Read more about BIO-key International's insider trading history. Receive BKYI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter. Email Address BKYI Stock News HeadlinesBIO-key International, Inc. (NASDAQ:BKYI) Q1 2025 Earnings Call TranscriptMay 20, 2025 | msn.comBiometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed.May 20, 2025 | globenewswire.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 24, 2025 | Timothy Sykes (Ad)BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle EastMay 19, 2025 | globenewswire.comEarnings call transcript: BIO-key Sees Q1 2025 Revenue Growth Amid ChallengesMay 18, 2025 | uk.investing.comBIO-key International, Inc. (BKYI) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comBIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ETMay 15, 2025 | globenewswire.comBIO-key International (BKYI) Expected to Announce Quarterly Earnings on ThursdayMay 14, 2025 | americanbankingnews.comSee More Headlines BKYI Stock Analysis - Frequently Asked Questions How have BKYI shares performed this year? BIO-key International's stock was trading at $1.71 at the beginning of the year. Since then, BKYI stock has decreased by 53.9% and is now trading at $0.7890. View the best growth stocks for 2025 here. How were BIO-key International's earnings last quarter? BIO-key International, Inc. (NASDAQ:BKYI) posted its quarterly earnings results on Thursday, May, 15th. The technology company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.24) by $0.08. The technology company had revenue of $1.61 million for the quarter, compared to the consensus estimate of $1.30 million. BIO-key International had a negative trailing twelve-month return on equity of 3,124.77% and a negative net margin of 72.53%. Read the conference call transcript. When did BIO-key International's stock split? BIO-key International shares reverse split on Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. How do I buy shares of BIO-key International? Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BIO-key International own? Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Exxon Mobil (XOM), Onconova Therapeutics (ONTX), T2 Biosystems (TTOO), Nokia Oyj (NOK), Electrameccanica Vehicles (SOLO), Tonix Pharmaceuticals (TNXP) and iBio (IBIO). Company Calendar Last Earnings5/15/2025Today5/24/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Prepackaged software Sub-IndustryComputer Software Current SymbolNASDAQ:BKYI CIK1019034 Webwww.bio-key.com Phone(732) 359-1100Fax732-359-1101Employees50Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,520,000.00 Net Margins-72.53% Pretax Margin-76.33% Return on Equity-3,124.77% Return on Assets-106.39% Debt Debt-to-Equity Ratio0.63 Current Ratio0.78 Quick Ratio0.71 Sales & Book Value Annual Sales$6.36 million Price / Sales0.72 Cash FlowN/A Price / Cash FlowN/A Book Value$1.03 per share Price / Book0.77Miscellaneous Outstanding Shares5,821,000Free Float2,946,000Market Cap$4.59 million OptionableNo Data Beta0.24 Social Links 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:BKYI) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIO-key International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIO-key International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.